na proteasome subunit beta also known proteasome subunit protein humans encoded protein one essential contribute complete assembly proteasome complex particular proteasome subunit beta along beta subunits assemble two heptameric rings subsequently proteolytic chamber substrate degradation eukaryotic proteasome recognizes degradable proteins including damaged proteins protein quality control purpose key regulatory protein components dynamic biological processes gene encodes member proteasome btype family also known family core beta subunit pseudogenes identified chromosomes gene exons locates chromosome band human protein proteasome subunit beta kda size composed amino acids calculated theoretical pi protein proteasome multicatalytic proteinase complex highly ordered core structure barrelshaped core structure composed axially stacked rings nonidentical subunits two end rings formed alpha subunits two central rings formed beta subunits three beta subunits contain proteolytic active site distinct substrate preferences proteasomes distributed throughout eukaryotic cells high concentration cleave peptides atpubiquitindependent process nonlysosomal protein functions supported tertiary structure interaction associating partners one subunits proteasome protein proteasome subunit beta contributes form proteolytic environment substrate degradation evidences crystal structures isolated proteasome complex demonstrate two rings beta subunits form proteolytic chamber maintain active sites proteolysis within concomitantly rings alpha subunits form entrance substrates entering proteolytic chamber inactivated proteasome complex gate internal proteolytic chamber guarded nterminal tails specific alphasubunit unique structure design prevents random encounter proteolytic active sites protein substrate makes protein degradation wellregulated proteasome complex usually functionally inactive proteolytic capacity core particle cp activated cp associates one two regulatory particles rp one side alpha rings regulatory particles include proteasome complexes proteasome complex etc following cprp association confirmation certain alpha subunits change consequently cause opening substrate entrance gate besides rps proteasomes also effectively activated mild chemical treatments exposure low levels sodium dodecylsulfate sds proteasome subunits clinical significance least two reasons compromised complex assembly dysfunctional proteasome associated underlying pathophysiology specific diseases exploited drug targets therapeutic interventions recently effort made consider proteasome development novel diagnostic markers strategies improved comprehensive understanding pathophysiology proteasome lead clinical applications future proteasomes form pivotal component system ups corresponding cellular protein quality control pqc protein ubiquitination subsequent proteolysis degradation proteasome important mechanisms regulation cell cycle cell growth differentiation gene transcription signal transduction subsequently compromised proteasome complex assembly function lead reduced proteolytic activities accumulation damaged misfolded protein species protein accumulation may contribute pathogenesis phenotypic characteristics neurodegenerative cardiovascular inflammatory responses autoimmune systemic dna damage responses leading several experimental clinical studies indicated aberrations deregulations ups contribute pathogenesis several neurodegenerative myodegenerative disorders including alzheimers parkinsons picks amyotrophic lateral sclerosis huntingtons disease disease motor neuron diseases polyglutamine polyq diseases muscular several rare forms neurodegenerative diseases associated part system ups proteasome maintains cardiac protein homeostasis thus plays significant role cardiac ischemic ventricular heart additionally evidence accumulating ups plays essential role malignant transformation ups proteolysis plays major role responses cancer cells stimulatory signals critical development cancer accordingly gene expression degradation transcription factors cjun cfos nfκb cmyc sterolregulated elementbinding proteins androgen receptors controlled ups thus involved development various moreover ups regulates degradation tumor suppressor gene products adenomatous polyposis coli apc colorectal cancer retinoblastoma rb von tumor suppressor vhl well number protooncogenes raf myc myb rel src mos abl ups also involved regulation inflammatory responses activity usually attributed role proteasomes activation nfκb regulates expression pro inflammatory cytokines tnfα ilβ adhesion molecules pselectin prostaglandins nitric oxide additionally ups also plays role inflammatory responses regulators leukocyte proliferation mainly proteolysis cyclines degradation cdk lastly autoimmune disease patients sle sjögren syndrome rheumatoid arthritis ra predominantly exhibit circulating proteasomes applied clinical shown interact crystal structure mammalian proteasome resolution